Reviewing Eternity Healthcare (OTCMKTS:ETAH) and Mettler-Toledo International (NYSE:MTD)

Mettler-Toledo International (NYSE:MTD) and Eternity Healthcare (OTCMKTS:ETAH) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, profitability, valuation, analyst recommendations, dividends and institutional ownership.

Analyst Ratings

This is a summary of current recommendations for Mettler-Toledo International and Eternity Healthcare, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mettler-Toledo International	0	7	6	0	2.46
Eternity Healthcare	0	0	0	0	0.00

Mettler-Toledo International presently has a consensus target price of $1,420.36, suggesting a potential upside of 0.13%. Given Mettler-Toledo International’s stronger consensus rating and higher possible upside, analysts plainly believe Mettler-Toledo International is more favorable than Eternity Healthcare.

Insider & Institutional Ownership

95.1% of Mettler-Toledo International shares are held by institutional investors. 0.7% of Mettler-Toledo International shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Mettler-Toledo International and Eternity Healthcare”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mettler-Toledo International	$4.03 billion	7.12	$869.19 million	$42.64	33.27
Eternity Healthcare	N/A	N/A	N/A	N/A	N/A

Mettler-Toledo International has higher revenue and earnings than Eternity Healthcare.

Profitability

This table compares Mettler-Toledo International and Eternity Healthcare’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Mettler-Toledo International	21.91%	-1,212.14%	25.11%
Eternity Healthcare	N/A	N/A	N/A

Summary

Mettler-Toledo International beats Eternity Healthcare on 8 of the 9 factors compared between the two stocks.

About Mettler-Toledo International

Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company’s retail weighing solutions consist of weighing and software solutions, AI-driven image recognition solution, and automated packaging and labelling solutions for the meat backroom. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is based in Columbus, Ohio.

About Eternity Healthcare

Eternity Healthcare, Inc. engages in the provision of stem cell storage and related medical therapies in China. Its services include cell derivation and cell banking. The company was founded on October 24, 2007 and is headquartered in Hong Kong.